A nitric oxide (.NO) spin-trapping technique combined with electron pa
ramagnetic resonance (EPR) spectroscopy has been employed to measure t
he in vivo production of .NO in lipopolysaccharide (LPS)-treated mice.
The in vivo spin-trapping of .NO was performed by injecting into mice
a metal-chelator complex, consisting of N-methyl-D-glucamine dithioca
rbamate (MGD) and reduced iron (Fe2+), that binds to .NO and forms a s
table, water-soluble [(MGD)(2)-Fe2+-NO] complex, and by monitoring con
tinuously the in vivo formation of the latter complex using an S-band
EPR spectrometer. At 6 h after intravenous injection of LPS, a three-l
ine EPR spectrum of the [(MGD)(2)-Fe2+-NO] complex, was observed in th
e blood circulation of the mouse tail; the [(MGD)(2)-Fe2+] complex was
injected subcutaneously 2 h before EPR measurement. No signal was det
ected in control groups. Administration of N-G-monomethyl-L-arginine,
an .NO synthase inhibitor, caused a marked reduction in the in vivo EP
R signal of the [(MGD)(2)-Fe2+-NO] complex, suggesting that the .NO de
tected is synthesized via the arginine-nitric oxide synthase pathway.
The results presented here demonstrated, for the first time, the in vi
vo real time measurement of .NO in the blood circulation of conscious,
LPS-treated animals.